Study to Evaluate the Feasibility of 13-C Pyruvate Imaging in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Hyperpolarized Pyruvate (13C) Injection|OTHER: Coil Testing|DRUG: NAC
Sponsor: Sunnybrook Health Sciences Centre